<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30688</article-id><article-id pub-id-type="doi">10.7554/eLife.30688</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>Genetically tunable frustration controls allostery in an intrinsically disordered transcription factor</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-94200"><name><surname>Li</surname><given-names>Jing</given-names></name><email>li@crystal.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94201"><name><surname>White</surname><given-names>Jordan T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3202-4181</contrib-id><email>jtwhite@email.wm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94202"><name><surname>Saavedra</surname><given-names>Harry</given-names></name><email>harryseg@yahoo.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94203"><name><surname>Wrabl</surname><given-names>James O</given-names></name><email>jowrabl@jhu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94204"><name><surname>Motlagh</surname><given-names>Hesam N</given-names></name><email>hesamnmotlagh@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94205"><name><surname>Liu</surname><given-names>Kaixian</given-names></name><email>kliu39@jhu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94206"><name><surname>Sowers</surname><given-names>James</given-names></name><email>jlsowers@utmb.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60880"><name><surname>Schroer</surname><given-names>Trina A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5065-1835</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94207"><name><surname>Thompson</surname><given-names>E Brad</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1578-0241</contrib-id><email>bthompso@utmb.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-15142"><name><surname>Hilser</surname><given-names>Vincent J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7173-0073</contrib-id><email>hilser@jhu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Biology</institution><institution>Johns Hopkins University</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">TC Jenkins Department of Biophysics</institution><institution>Johns Hopkins University</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry</institution><institution>University of Houston</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1018"><name><surname>Kuriyan</surname><given-names>John</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e30688</elocation-id><history><date date-type="received" iso-8601-date="2017-07-24"><day>24</day><month>07</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-10-11"><day>11</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Li et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Li et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-30688-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary" xlink:href="10.7554/eLife.32762"/><related-object ext-link-type="url" xlink:href="https://elifesciences.org/articles/e30688v1"><date date-type="v1" iso-8601-date="2017-10-12"><day>12</day><month>10</month><year>2017</year></date></related-object><abstract><object-id pub-id-type="doi">10.7554/eLife.30688.001</object-id><p>Intrinsically disordered proteins (IDPs) present a functional paradox because they lack stable tertiary structure, but nonetheless play a central role in signaling, utilizing a process known as allostery. Historically, allostery in structured proteins has been interpreted in terms of propagated structural changes that are induced by effector binding. Thus, it is not clear how IDPs, lacking such well-defined structures, can allosterically affect function. Here, we show a mechanism by which an IDP can allosterically control function by simultaneously tuning transcriptional activation and repression, using a novel strategy that relies on the principle of ‘energetic frustration’. We demonstrate that human glucocorticoid receptor tunes this signaling in vivo by producing translational isoforms differing only in the length of the disordered region, which modulates the degree of frustration. We expect this frustration-based model of allostery will prove to be generally important in explaining signaling in other IDPs.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.30688.002</object-id><title>eLife digest</title><p>Proteins carry out most of the key tasks inside cells. To perform these roles, proteins must fold up to form complex three-dimensional structures. Researchers used to think that the useful parts of proteins all had set structures. However, we now know that ‘disordered’ proteins with variable structures are common and disordered parts of proteins can have vital roles.</p><p>In a process called allosteric regulation, regulator molecules can increase or decrease the activity of a protein by binding to it. This binding was thought to work by changing the structure of the protein, but it was not clear how this works in disordered proteins. To investigate, Li et al. studied a disordered protein called glucocorticoid receptor, and found that disordered regions can have opposing effects on other regions of the protein. This creates a ‘tug-of-war’ that Li et al. term “energetic frustration”, whereby the activity of the protein results from the combination of the opposing interactions.</p><p>Further investigation revealed that the glucorticoid receptor produces different versions of itself that have different degrees of energetic frustration, which alters how effectively the proteins perform their tasks. This means that the protein can regulate its own activity even in the absence of binding to regulator molecules.</p><p>The concept of energetic frustration could enhance our understanding of the many different proteins that contain disordered regions. Eventually, this knowledge could be used to develop drugs that alter the activity of these proteins and so could form part of treatments for a wide range of conditions including autoimmune diseases (such as rheumatoid arthritis and lupus), cancers, and organ rejection for transplant patients. The results presented by Li et al. suggest where more research is needed to achieve this goal. For example, we need to understand more about the stability of disordered protein regions, and to identify which surfaces of the proteins interact with each other.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>allostery</kwd><kwd>frustration</kwd><kwd>disorder</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>MCB-1330211</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Jing</given-names></name><name><surname>White</surname><given-names>Jordan T</given-names></name><name><surname>Saavedra</surname><given-names>Harry</given-names></name><name><surname>Wrabl</surname><given-names>James O</given-names></name><name><surname>Motlagh</surname><given-names>Hesam N</given-names></name><name><surname>Liu</surname><given-names>Kaixian</given-names></name><name><surname>Sowers</surname><given-names>James</given-names></name><name><surname>Hilser</surname><given-names>Vincent J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM-063747</award-id><principal-award-recipient><name><surname>Motlagh</surname><given-names>Hesam N</given-names></name><name><surname>Wrabl</surname><given-names>James O</given-names></name><name><surname>Hilser</surname><given-names>Vincent J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32-GM008403</award-id><principal-award-recipient><name><surname>Motlagh</surname><given-names>Hesam N</given-names></name><name><surname>Wrabl</surname><given-names>James O</given-names></name><name><surname>Hilser</surname><given-names>Vincent J</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007880</institution-id><institution>Johns Hopkins University</institution></institution-wrap></funding-source><award-id>JHU Institutional Funds</award-id><principal-award-recipient><name><surname>Hilser</surname><given-names>Vincent J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Allostery in an intrinsically disordered domain of glucocorticoid receptor is mediated by opposing thermodynamic signals that are directed through the production of different isoforms.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>A cornerstone of biological regulation is the ability of proteins to tune their particular activities in response to the binding of specific ligands at distinct regulatory sites (<xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>). Historically, such tunability has been explained by the concerted (<xref ref-type="bibr" rid="bib34">Monod et al., 1965</xref>) or sequential (<xref ref-type="bibr" rid="bib24">Koshland et al., 1966</xref>) models of allosteric regulation, which describe the coupling between binding sites in terms of ligand-induced changes in the average structure of the protein. More recent studies reveal that allostery is not restricted to structured proteins. It is widely observed in intrinsically disordered (ID) proteins, polypeptides, or regions therein, that lack stable tertiary structure (<xref ref-type="bibr" rid="bib10">Ferreon et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Garcia-Pino et al., 2010</xref>; <xref ref-type="bibr" rid="bib32">Lum et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Sevcsik et al., 2011</xref>). Moreover, ID regions are hyper-abundant in known allosteric proteins such as transcription factors (<xref ref-type="bibr" rid="bib16">Gronemeyer and Bourguet, 2009</xref>; <xref ref-type="bibr" rid="bib29">Liu et al., 2006</xref>), suggesting that allostery involving ID sequences may represent a major regulatory paradigm. Despite the existing evidence, however, the mechanism by which ID proteins facilitate allostery is not known.</p><p>Previously, we developed a mathematical model to show how proteins could use intrinsic disorder to facilitate, and even optimize, allosteric control (<xref ref-type="bibr" rid="bib20">Hilser and Thompson, 2007</xref>). This model predicts that coupled folding and binding in different ID domains could produce complex coupling mechanisms that result from the simultaneous tuning of both activating and repressing sub-ensembles within the overall conformational ensemble (<xref ref-type="bibr" rid="bib19">Hilser et al., 2006</xref>, <xref ref-type="bibr" rid="bib22">2012</xref>; <xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>), a process of ‘energetic frustration’ akin to the well-known physical concept of ‘geometric frustration’. In condensed matter physics, ‘geometric frustration’ describes a physical system’s inability to simultaneously minimize the competing interaction energies between its components in mean field theory (<xref ref-type="bibr" rid="bib47">Vannimenus and Toulouse, 1977</xref>; <xref ref-type="bibr" rid="bib48">Villain, 1977</xref>). Frustration theory has been invaluable in understanding magnetic and superconducting systems (<xref ref-type="bibr" rid="bib47">Vannimenus and Toulouse, 1977</xref>), circuits (<xref ref-type="bibr" rid="bib49">Wang et al., 2006</xref>), protein folding (<xref ref-type="bibr" rid="bib4">Bryngelson and Wolynes, 1987</xref>), and even gene networks (<xref ref-type="bibr" rid="bib26">Krishna et al., 2009</xref>). However, whereas numerous biological networks can utilize multiple components (e.g. repressors and activators) to control overall activity, it is not known whether a single gene product could encode tunable activity based on an analogous form of frustration, as theory predicts (<xref ref-type="bibr" rid="bib19">Hilser et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Hilser et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>).</p><p>To investigate the relationship between disorder and allostery and to test whether energetic frustration is at the heart of disorder-mediated allostery, we selected the human glucocorticoid receptor (GR) as a model system. The GR is a member of the steroid hormone receptor (SHR) family of transcription factors and plays key roles in organ development, metabolite homeostasis, and the responses to stress and inflammation (<xref ref-type="bibr" rid="bib15">Griekspoor et al., 2007</xref>). Three major domains segregate the GR’s primary functions (<xref ref-type="bibr" rid="bib21">Hilser and Thompson, 2011</xref>). The DNA-binding domain (DBD) and ligand-binding domain (LBD) are well-structured and are responsible for interacting with DNA (i.e. GR response element) and the steroid hormone (e.g. cortisol), respectively (<xref ref-type="bibr" rid="bib21">Hilser and Thompson, 2011</xref>). The N-terminal domain (NTD), which consists of the first 420 amino acids, contains the activation function 1 core region (i.e. AF1c, GR 187–244), which is required for the recruitment of cofactors necessary for transcriptional activation (<xref ref-type="bibr" rid="bib8">Dahlman-Wright et al., 1994</xref>; <xref ref-type="bibr" rid="bib11">Ford et al., 1997</xref>) and full transcriptional potency. In contrast to the LBD and DBD, the NTD of GR is intrinsically disordered (<xref ref-type="bibr" rid="bib21">Hilser and Thompson, 2011</xref>). Importantly, five active isoforms (<xref ref-type="fig" rid="fig1">Figure 1</xref>, Inset) among the total of eight translational isoforms of GR (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), differing only in the lengths of the ID NTDs have been discovered (<xref ref-type="bibr" rid="bib30">Lu and Cidlowski, 2005</xref>). These isoforms differ in their relative activities (<xref ref-type="bibr" rid="bib3">Bender et al., 2013</xref>), tissue distributions (<xref ref-type="bibr" rid="bib30">Lu and Cidlowski, 2005</xref>; <xref ref-type="bibr" rid="bib31">Lu and Cidlowski, 2006</xref>), and regulatory specificities (<xref ref-type="bibr" rid="bib3">Bender et al., 2013</xref>; <xref ref-type="bibr" rid="bib6">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Lu and Cidlowski, 2005</xref>; <xref ref-type="bibr" rid="bib31">Lu and Cidlowski, 2006</xref>). Although the effect of binding either different steroid molecules (<xref ref-type="bibr" rid="bib38">Pandit et al., 2002</xref>; <xref ref-type="bibr" rid="bib40">Pfaff and Fletterick, 2010</xref>) or different DNA sequences (<xref ref-type="bibr" rid="bib33">Meijsing et al., 2009</xref>) is known to produce a variety of structural changes within their respective binding domains, how such binding events are differentially propagated to the ID NTD of each isoform, and subsequently translated into functional changes, is not known. Fundamentally, it is not clear whether and, if so, how structured domains like the DBD can both receive and transmit allosteric signals to disordered domains like the NTD of GR.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30688.003</object-id><label>Figure 1.</label><caption><title>Transcriptional activity and DNA-binding affinity are not correlated among GR translational isoforms.</title><p>Transcriptional activity, monitored by dual luciferase reporter assay (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a and b''</xref>), and binding affinity to DNA, monitored by fluorescence anisotropy change (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c and d</xref>), show uncorrelated behavior. <bold>Inset</bold>: Domain organization of the constitutively active GR constructs for translational isoforms, wherein the intrinsically disordered N terminal domain (NTD) varies in length. Residues 1–97 (red) are labeled R (for Regulatory) and residues 98–420 (grey) are labeled F (for Functional). Also labeled are residues corresponding to the activation function 1 core (AF1 core) region, which is required for transcriptional activity (<xref ref-type="bibr" rid="bib11">Ford et al., 1997</xref>). Error bars represent uncertainty of the individual fits.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30688.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Transcriptional activity and DNA-binding affinity of GR translational isoforms.</title><p>(<bold>a</bold>) Luciferase assay dosage curves for the constitutively active constructs of the eight GR translational isoforms. Per 30,000 cells, a constant 40 ng of GRE-driven luciferase vector was transfected, and the amount of GR vector co-transfected was increased from 0 ng to 5 ng. Errors are calculated from three samples. Curves are fitted to the data using the dose-response function, <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo form="prefix" movablelimits="true">max</mml:mo></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo fence="true" maxsize="1.2em" minsize="1.2em" stretchy="true" symmetric="true">/</mml:mo></mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>P</mml:mi></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula>. <italic>A</italic><sub>max</sub> represents the maximum transcriptional activity for each construct, and <italic>EC</italic><sub>50</sub> represents the amount of GR construct transfected at the half-maximum transcriptional activity. <italic>C</italic> is the amount of GR construct transfected at each data point. p is an empirical value introduced in the fitting equation, to transform DNA vector amount to protein expression amount, to account for the possibility that different isoforms have different degradation rates, expression levels, nuclear localizations and/or cooperativities. Inset: Western blot showing that U-2 OS cells transiently transfected with the expression plasmid for each isoform express each of them. (<bold>b</bold>) Luciferase assay dosage curve keeping each GR isoform vector constant at 4 ng per 30,000 cells, while gradually increasing the GRE-driven luciferase vector from 0 ng to 40 ng. Data were fitted by a linear function. (This indicates that 5 ng GR isoform construct can saturate the 40 ng GRE driven luciferase vector.) Errors are the standard deviations of three independent samples. (<bold>c</bold>) Fluorescence anisotropy of the 6-FAM-labeled half site GRE (5’-gcgcAGAACAggagcgc-3’) as a function of GR translational isoform concentration. Binding was conducted with 25 nM 6-FAM labeled GRE in buffer containing 10 mM HEPES (pH7.6), 80 mM NaCl, 1 mM EDTA, 5 mM MgCl<sub>2</sub>, 1 mM DTT, 10% glycerol, 200 ug/mL BSA and 5 µM control non-specific 17-mer oligo. Curves represent fits to the data with a single-site-binding model. (<bold>d</bold>) Correlation between the <italic>EC</italic><sub>50</sub> fitted from the in vivo dosage curve as shown in panel a and the in vitro binding affinity as shown in panel c, demonstrating that the in vitro binding affinity represents the in vivo binding. Error bars represent uncertainty of the fits, as returned by the default settings of <italic>Mathematica’s NonLinearModelFit</italic> function. (<bold>e</bold>) Competitive transfection assay comparing D1, D2, D3 and DBD, against titration of a constant amount of C3 isoform (which has the highest activity). The transcription activity of C3 isoform in absence of competitors was normalized to 1. Data were fitted with dose-response function, <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo fence="true" maxsize="1.2em" minsize="1.2em" stretchy="true" symmetric="true">/</mml:mo></mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>P</mml:mi></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula>. In this equation, <italic>A</italic><sub>competitor</sub> represents the transcriptional activity when 16 ng of competitor is transfected alone, <italic>EC</italic><sub>50</sub> represents the co-transfected amount of competitor construct that results in half the activity of the C3 maximum. <italic>C</italic> is the amount of competitor construct transfected at each data point. p is an empirical value described in panel a. Inset: correlation between the <italic>EC</italic><sub>50</sub> fitted from the competitive binding assay and the in vitro measured binding affinity for D1, D2 and D3 isoforms (as obtained from panel c). Errors reflect uncertainties of the individual fits, as returned by the default settings of <italic>Mathematica’s NonLinearModelFit</italic> function. The correlation demonstrates that the competitive transfection assay provides qualitative information about the binding affinity of each inactive construct. (<bold>f</bold>). Multicolor immunostaining of U-2 OS cells transfected with A, B, C1, C2, C3, D1, D2 and D3 constructs. Green: Alexa 488 linked goat anti-mouse IgG staining GR. Blue: DAPI staining nuclei. Red: Rhodamine Phalloidin staining F-actin. (<bold>g</bold>) Nuclear localization efficiency for the eight GR translational isoforms. Nuclear percentage is calculated by dividing the intensity of the green dye overlapped with blue dye with the total green dye intensity as shown in panel f. Three pictures were used for each isoform for the quantification. Average values and standard errors of the mean are reported in the graph.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig1-figsupp1-v2"/></fig></fig-group></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><sec id="s2-1"><title>Thermodynamic coupling underlies tunable DNA-binding affinity and transcriptional activity of different isoforms</title><p>To obtain insight into how allostery tunes GR function, DNA binding and cell-based functional studies were performed on constitutively active (i.e. steroid-independent) versions (<xref ref-type="bibr" rid="bib7">Chen et al., 1997</xref>) of human GR translational isoforms that lack the C-terminal LBD (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The similarity between the relative transcriptional activities of the different two-domain isoforms studied here and those of the full-length three-domain isoforms studied previously (<xref ref-type="bibr" rid="bib3">Bender et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Lu and Cidlowski, 2005</xref>) (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a and b''</xref>), suggests that although the LBD affects the magnitude of activity enhancement (<xref ref-type="bibr" rid="bib14">Godowski et al., 1987</xref>; <xref ref-type="bibr" rid="bib23">Hollenberg and Evans, 1988</xref>), it does not appear to qualitatively impact the communication between the DBD and the NTD in each isoform.</p><p>Several features of the activities and DNA-binding properties of the different isoforms are noteworthy. First, the affinities of the isoforms for DNA vary, despite having identical DBDs, indicating that the NTD of each isoform differentially communicates with its respective DBD (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c–e</xref>). Second, the GR C3 isoform (i.e. 98–525) is almost five times more active than the full-length GR A isoform (i.e. 1–525), indicating that residues 1–97 somehow negatively regulate the activity of the remaining NTD residues, which contain the functionally important AF1c region (<xref ref-type="fig" rid="fig1">Figure 1</xref>). For this reason, we represent the full-length NTD as being composed of two distinct domains, a functional domain (F-domain), and a regulatory domain (R-domain) (<xref ref-type="fig" rid="fig1">Figure 1</xref>, Inset), which were experimentally shown to be unfavorably coupled to each other by both osmolyte (i.e. TMAO) induced folding and protease sensitivity analyses (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref>) (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>). Conversely, in the same in vitro folding and protease sensitivity experiments the DBD appears to stabilize the folded form of the F-domain (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref>). Importantly, the thermodynamic stabilization of the F-domain conferred by the DBD is accompanied by a dramatic increase in activity, as determined from cell-based transcriptional assays that compare the activity of the GR F-DBD construct (C3 isoform) with the non-natural chimera that tethers the DBD from the yeast Gal4 transcription factor to the F-domain (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). The thermodynamic and activity results suggest that competing factors within GR determine the overall stability (i.e. the ΔG of folding) and transcriptional activity of the AF1c region of the F-domain.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.30688.005</object-id><label>Figure 2.</label><caption><title>Coupling of the R-domain and DBD to the functional F-domain in GR.</title><p>(<bold>a</bold>) TMAO-induced folding for the F-domain alone and with either the R-domain or the DBD. (<bold>b</bold>) Protease sensitivity assay: comparing F-domain and F-domain with R-domain (left) performed at a protein (1 mg/ml): trypsin mass ratio of 1000:1 (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>); comparing F-domain and F-domain with DBD (right) performed at a protein (1 mg/ml): trypsin mass ratio of 100:1. Note: each protein pair (i.e. F vs. R-F and F vs. F-DBD) was run on the same gel, with the intervening lanes removed in the figure for clarity. (<bold>c</bold>) Luciferase assay for C3 isoform (GR F-DBD) versus chimeric construct (GR F-Gal4 DBD).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30688.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Domain stabilities determined by TMAO-induced protein folding transitions.</title><p>(<bold>a</bold>) Thermodynamic parameters obtained from TMAO-induced folding experiments demonstrate that DBD stabilizes a folded conformation of the F-domain while the R-domain destabilizes that conformation. Parameter values obtained from the fits of the TMAO-induced folding data for the constructs shown in <xref ref-type="fig" rid="fig2">Figure 2a</xref>. See previous publication (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>) for details. Because the thermodynamic analyses report on the free energy differences and not the mechanistic bases of the energy differences, the reported free energies of folding (<inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mi>G</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>U</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mstyle></mml:math></inline-formula>) may not necessarily reflect the stability of unique conformations. Instead, they may be reporting on the stability of a conformationally heterogeneous ensemble. Toward this end, it has been reported that ID proteins may adopt poly-beta sheet formations (<xref ref-type="bibr" rid="bib17">Han et al., 2012</xref>) as part of their functional states. As the effect of TMAO on structure is almost entirely defined by the influence on backbone atoms (i.e. excluding backbone hydrogen bond donors and acceptors from solvent) (<xref ref-type="bibr" rid="bib1">Auton and Bolen, 2005</xref>), any state or ensemble of states that facilitates removal of backbone atoms from solvent will be stabilized by TMAO. As such, the current analysis provides evidence that a functional state exists whose probability is proportional to transcriptional activation. However, the structural properties of that state are not known. (<bold>b</bold>) Comparison of the <italic>m-values</italic> fitted from TMAO induced folding of F-domain and R-F with the published <italic>m-values</italic> for known representative globular proteins (see previous publication (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>) for details). The <italic>m-value</italic> comparison suggests that the F-domain and R-domain can adopt folded conformations similar to globular proteins in terms of surface area buried upon folding.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig2-figsupp1-v2"/></fig></fig-group><p>The coupling between the R-domain and the DBD was further evaluated by use of competitive transfection assays to estimate the DNA-binding affinity of various constructs that connect the DBD and the R-domain of each isoform. In order to only measure the coupling between the R-domain and the DBD, and to avoid the convoluting effects associated with the coupling between the F-domain and the R-domain and DBD, constructs were generated that utilized a series of flexible linkers connecting the R-domain to the DBD (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). As <xref ref-type="fig" rid="fig3">Figure 3b</xref> reveals, inclusion of the R-domain residues 1–85, naturally present in GR’s A and B isoforms, significantly increased the DNA-binding affinity of the DBD, while the shorter length R-domains in the C isoforms show no effect. Such increases were not observed for non-natural chimeric constructs that linked the various R-domains to the yeast transcription factor Gal4 DBD (<xref ref-type="bibr" rid="bib25">Kraulis et al., 1992</xref>) (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). In addition, the fact that different length linkers (<xref ref-type="fig" rid="fig3">Figure 3c</xref>) give similar results indicates that the linker is, as intended, functionally inert, and serving as a tether that simply connects the R-domain to the DBD. These results support the notion that the R-domain affects DNA binding by the DBD specifically through stabilization of a high-affinity state of the DBD, and is not simply a consequence of a direct interaction between the R-domain (or the linker) and the DNA. In other words, our results indicate the R-domain allosterically affects DNA binding of the DBD, serving as a positive intramolecular allosteric effector.</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.30688.007</object-id><label>Figure 3.</label><caption><title>Coupling between the R-domain and DBD in GR.</title><p>(<bold>a</bold>) Schematic representation of competitive transfection assay design for constructs of the R-domains of isoforms A, B, C1, and C2 as well as the internally truncated R-domain linked to GR DBD or Gal4 DBD. (<bold>b</bold>) Experimental competitive transfection assay for constructs shown in a. The first 86 residues of R-domain present in GR A and B isoforms significantly increase the binding affinity of the DBD to GRE. Linking the R-domains to the Gal4 DBD ablate coupling. (<bold>c</bold>) Linkers of 11aa and 20aa were compared for the effect when connected alone to the GR DBD or used to link the R-domain (GR 1–97 segment) to the DBD. Linker length in panel a and all the other figures is 11aa. Error bars represent uncertainty of the individual fits.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig3-v2"/></fig></sec><sec id="s2-2"><title>Energetic frustration in GR</title><p>The analysis of the thermodynamic couplings in <xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref> point to the paradoxical result whereby the binding of DNA to the DBD simultaneously produces two opposing effects on the F-domain. It has long been known that DNA binding to GR DBD stabilizes the DBD (<xref ref-type="bibr" rid="bib27">Lefstin and Yamamoto, 1998</xref>). As a consequence of its direct positive coupling to the F-domain (<xref ref-type="fig" rid="fig2">Figure 2</xref>), DBD binding to DNA stabilizes the folded form of the F-domain and therefore promotes activation of transcription (<xref ref-type="fig" rid="fig4">Figure 4a</xref>, counterclockwise green arrow). However, as <xref ref-type="fig" rid="fig3">Figure 3</xref> indicates, there is also positive coupling between the DBD and the R-domain. But because of the negative coupling between the R- and F-domains (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref>), the same DNA binding (to the DBD) that stabilizes/activates the F-domain simultaneously, through stabilization of the R-domain, destabilizes the folded form of the F-domain, promoting repression of transcription (<xref ref-type="fig" rid="fig4">Figure 4a</xref>, red inhibitory semicircle), a process that resembles geometric frustration (<xref ref-type="bibr" rid="bib47">Vannimenus and Toulouse, 1977</xref>; <xref ref-type="bibr" rid="bib48">Villain, 1977</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.30688.008</object-id><label>Figure 4.</label><caption><title>Competing thermodynamic coupling in GR produces frustration.</title><p>(<bold>a</bold>) Schematic view of the thermodynamic configuration of GR. According to this convention, the positive (+) signs between the DBD and F-domain, and the DBD and R-domain signify they are positively coupled; stabilization of one domain stabilizes the other. The negative (-) sign between the R- and the F- domains indicate they are negatively coupled; stabilization of one domain destabilizes the other. Thus, the combination of the positive coupling between DBD and R-domain, and the negative coupling between R- and F-domains produces an overall repression (red semicircle) from the effect that is mediated through the R-domain. Triplet arrows are an abbreviation to describe all the couplings in the system: first arrow indicates the coupling between DBD and F-domain, second arrow indicates coupling between R-domain and F-domain, and third arrow indicates coupling between DBD and R-domain. Green (up) arrow indicates positive coupling and red (down) arrow indicates negative coupling. Importantly for this equilibrium scheme, any permutation containing an even number of up arrows will be energetically frustrated. (<bold>b</bold>) Schematic representation of all possible thermodynamic configurations for three interacting domains (represented in the structural and spin (up or down arrows) nomenclatures). Four of the possible configurations produce frustration between the DBD and the F-domain (top), whereas four configurations do not produce frustration (bottom), representing the cases of activation and repression, respectively. Note the curved arrows connecting the domains are colored according to the overall effect on F-domain from stabilizing the DBD; this coloring scheme highlights the result that frustrated configurations result from opposing energetic couplings affecting the F-domain stability. For example, in case i (Top, Left), stabilization of the DBD destabilizes the R-domain due to the negative coupling energy, signified by the red curved arrow between domains. However, the destabilization of the R- domain has the effect of also destabilizing the F-domain, because the F- and R- domains are positively coupled. Thus, the overall effect of stabilizing the DBD is to destabilize the F-domain through its interaction with the R-domain, signified by the red curved arrow between the R- and F- domains (even though the coupling between R-F alone is positive).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig4-v2"/></fig><p>Geometric frustration originates in bi-stable systems wherein competing thermodynamic couplings interact such that no single state acquires significant stability so as to dominate the ensemble probabilities (<xref ref-type="bibr" rid="bib26">Krishna et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Vannimenus and Toulouse, 1977</xref>; <xref ref-type="bibr" rid="bib48">Villain, 1977</xref>). Within the context of the three domains of GR studied here, eight different configurations of coupling energies (i.e. <xref ref-type="fig" rid="fig4">Figure 4bi–viii</xref>) represent all possible combinations of positive (+) and negative (−) coupling energies between domains. For each case, a positive interaction energy signifies that a stabilization of one domain would result in a stabilization of the second domain, whereas negative coupling would produce the opposite effect. As <xref ref-type="fig" rid="fig4">Figure 4b</xref> reveals, frustration results when the ‘direct’ impact of stabilization of the DBD on the F-domain is opposite in sign to the indirect impact (i.e. the impact that is mediated through the R-domain). Such is the case when one or all three of the inter-domain interactions is/are negative (<xref ref-type="bibr" rid="bib22">Hilser et al., 2012</xref>; <xref ref-type="bibr" rid="bib35">Motlagh and Hilser, 2012</xref>; <xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>). Of the possible configurations that are predicted to produce frustration (<xref ref-type="fig" rid="fig4">Figure 4b</xref> upper), GR clearly conforms to case ii, wherein the DBD is positively coupled to the F-domain serving to increase its activity (<xref ref-type="fig" rid="fig2">Figure 2a–c</xref>). However, because of the negative coupling between the R-domain and the F-domain (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref>), and the positive coupling between the R-domain and the DBD (<xref ref-type="fig" rid="fig3">Figure 3</xref>), the DBD is ultimately also negatively coupled to the F-domain. The net effect of DNA binding on GR transcriptional activity is thus a balance between the strengths of these coupling energies, which could differ among translational isoforms. The results clearly demonstrate that two opposing control mechanisms are at play, and that the classic deterministic models of allostery (<xref ref-type="bibr" rid="bib24">Koshland et al., 1966</xref>; <xref ref-type="bibr" rid="bib34">Monod et al., 1965</xref>) are insufficient to capture the probabilistic nature of this mechanism.</p><p>To highlight the analogy with geometric frustration, while simultaneously distinguishing this biological phenomenon from the condensed matter physics model, we term this phenomenon ‘energetic frustration’. The simplest models for geometric frustration quantify the total energy of a system of spins within a magnet, where the energy of an interacting spin pair of nuclei <italic>i</italic> and <italic>j</italic> takes the form <italic>E<sub>int</sub> = J<sub>ij</sub>S<sub>i</sub>S<sub>j</sub></italic>. In this formalism, <italic>J</italic> is the coupling energy and <italic>S</italic> is the spin state (i.e. ‘up +1’ or ‘down −1’). The interaction energy between protein domains <italic>i</italic> and <italic>j</italic> can be written in a similar way, <italic>E<sub>int</sub> = J<sub>ij</sub>S*<sub>i</sub>S*<sub>j</sub></italic>, with an interdomain coupling energy and an accounting for the states of the domains. One key difference, with respect to geometric frustration, is that in energetic frustration the sign of <italic>E<sub>int</sub></italic> is determined solely by the sign of <italic>J</italic>, which is fixed by the physicochemical nature of the interdomain interaction. Also, the domain state is conditional on whether the protein domain is folded or unfolded, a folded state resulting in a + 1 value for <italic>S*</italic> and an unfolded state resulting in a value of 0. Only in the case in which both domains are folded will the coupling energy contribute to the system.</p></sec><sec id="s2-3"><title>The ensemble allosteric model (EAM) enables quantitative characterization of the energetic frustration in GR</title><p>To illuminate how the opposing allosteric mechanisms are manifested in our example IDP, the GR, a quantitative characterization of the allosteric coupling was implemented using the previously developed ensemble allosteric model (EAM) (<xref ref-type="bibr" rid="bib20">Hilser and Thompson, 2007</xref>; <xref ref-type="bibr" rid="bib22">Hilser et al., 2012</xref>). An ensemble of states was constructed for each isoform, enumerating all possible combinations of the DBD being in the high-affinity or low-affinity states, and the R and F-domains being in their active (folded) or inactive (unfolded) states (see <xref ref-type="fig" rid="fig5">Figure 5a</xref>, for the A and C3 isoforms). Our choice of model is justified because as shown previously (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>) the R- and F-domains can fold to globular protein-like structures (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>), consistent with the notion of coupled folding and binding for IDPs, where the folded conformation is the active form (<xref ref-type="bibr" rid="bib9">Dyson and Wright, 2002</xref>). In the context of the EAM, the probability of any state is determined by the intrinsic stability of each domain, ∆G<sub>R</sub>, ∆G<sub>F</sub> and ∆G<sub>D</sub> (the stability of each domain as it would be in isolation), as well as the coupling free energies between each domain, <inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>−</mml:mo><mml:mi>F</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>−</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (<xref ref-type="bibr" rid="bib20">Hilser and Thompson, 2007</xref>; <xref ref-type="bibr" rid="bib22">Hilser et al., 2012</xref>). For example, in the full length A isoform (composed of the R-domain, the F-domain, and the DBD) and the most active C3 isoform (composed only of the F-domain and the DBD), the EAM produces 8 and 4 states in their respective ensembles, representing all combinations (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). In the EAM, the experimentally observed transcriptional activity is represented by the summed probabilities of states whose folded F-domain co-occurs with the high-affinity DBD conformation. Similarly, DNA-binding affinity is represented by the summed probabilities of states wherein the DBD is in the high-affinity conformation.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.30688.009</object-id><label>Figure 5.</label><caption><title>The ensemble allosteric model (EAM) quantitatively describes GR transcriptional activation.</title><p>(<bold>a</bold>) EAM for GR A and C3 isoforms. (<bold>b</bold>) The model recapitulates the DNA-binding affinity and relative transcriptional activity of A, B, C1, C2, and C3 isoforms. Error bars on experimental data represent uncertainty of the individual fits. Error bars on simulated data are average results from propagation of experimental error through the model.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30688.010</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Probability distribution of each thermodynamic parameter from EAM.</title><p>Two independent methods were used to estimate parameters for the EAM from experimental data. The first method was a ‘brute force’ grid search for parameter combinations that satisfied the experimental transcriptional activity and binding affinity data, and the second method used unbiased global minimization of a chi-squared merit function against the experimental transcriptional activity and binding affinity data, as implemented in the attached <italic>Mathematica</italic> notebook. Panels a-d are relevant to the first method, and panels e-f demonstrate that the resulting estimates from both methods were robustly similar in sign and magnitude. The first method was exhaustive subject to the following reasonable parameter space constraints (the second method was subject to no constraints): (1) full length isoform A has higher binding affinity and lower transcriptional activity than C3 isoform (as experimentally demonstrated in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a–d</xref>); (2) The probability of the high-affinity state of A isoform is less than 40%, as A isoform’s binding affinity is more than 2.5 fold lower than D2 isoform, which has highest binding affinity among all the translational isoforms (as experimentally demonstrated in <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c–d</xref>); (3) R<sub>A</sub>-linker-DBD construct has higher binding affinity than linker-DBD construct (as experimentally demonstrated in <xref ref-type="fig" rid="fig3">Figure 3b</xref>); (4) In presence of GR response element, the sum of probability of the functional states (with F-domain in the folded conformation and the DBD in the high-affinity state) is larger than 5%, which is consistent with the possibility of a large population increase upon a small energetic stabilization, such as a binding event to co-regulators. During the parameter space search, each stability term was explored from −8 kcal/mol to +8 kcal/mol, with a step size of 0.25 kcal/mol, thus the search was exhaustive within a resolution of that increment. (<bold>a</bold>) Probability distribution plot of the stability of the F-domain, the R-domain and the DBD (with the folded conformation or high-affinity state as reference). (<bold>b</bold>) Probability distribution plot of the interaction energy between the R-domain and the F-domain, the R-domain and the DBD and the F-domain and the DBD. As shown in panel a, the distribution of the F-domain stability has high uniform probability between −7.5 kcal/mol and −2 kcal/mol, consistent with its experimental stability of −7.6 ± 0.3 kcal/mol measured by in vitro TMAO folding (<xref ref-type="fig" rid="fig2">Figure 2a</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>). Thus, to save computational time, the parameter space search was carried out again by fixing F-domain stability at −7 kcal/mol and exhaustively scanning the other parameters. Under such conditions, the probability distribution of the stabilities of the R-domain and the DBD are shown in panel <bold>c</bold> and the distributions of the interaction energies between domains are shown in panel <bold>d</bold>. A range of parameter combinations can satisfy the experimental constraints, but it is important to emphasize that with no parameter does the sign of the energy change. With any such set of parameter combinations, the simulated transcriptional activity and the simulated binding affinity of C3 isoform can be calculated as relative to A isoform. Calculating the RMSD between these simulated values and experimental data was employed as a useful heuristic to assess which sets of the parameter combinations best simulated the experimental observations. Another useful heuristic, a ‘distribution score’, was employed to assess how well a chosen parameter compared to the mode of its distribution. One arbitrarily chosen set of parameters exhibiting reasonable compromise between a minimum RMSD and a maximum ‘distribution score’ was the following: (<inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>=−1.0 kcal/mol, <inline-formula><mml:math id="inf8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = 0.75 kcal/mol, <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = −7 kcal/mol, <inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>−</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> = 0.75 kcal/mol, <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>= −1.75 kcal/mol, and <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>= 7.0 kcal/mol (positions of these values were labeled with dashed lines in panels c and d). This set was used to calculate the simulated transcriptional activity and binding affinity from EAM as shown in <xref ref-type="fig" rid="fig5">Figure 5b</xref>, <xref ref-type="fig" rid="fig6">Figure 6b and e</xref>, and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1g–i</xref>. (<bold>e</bold>) Domain stabilities and interaction energies estimated by the two methods are similar in sign and magnitude. To demonstrate robustness of the global minimization, experimental errors from the stability measurements were propagated through the model. Error bars represent the standard deviations of 10 independent minimizations. (<bold>f</bold>) Parameter estimates from both methods were used with the EAM to compute expected transcriptional activity and binding affinity. Reasonable agreements with experiment data were obtained from both methods.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig5-figsupp1-v2"/></fig></fig-group><p>Using measurements of transcriptional activities and binding affinities of the five isoforms (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a–d</xref>), measurements of relative binding affinities of R<sub>A</sub>-linker-DBD and Linker-DBD constructs (<xref ref-type="fig" rid="fig3">Figure 3b</xref>), and measurements of conformational stabilities (<xref ref-type="fig" rid="fig2">Figure 2a</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>) as constraints, quantitative estimates of the stabilities and coupling energies for each domain were obtained through unbiased comprehensive searches of parameter space (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a</xref>). Importantly, the maximum likelihood parameters (shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1e</xref>) faithfully reproduce both the relative affinities and transcriptional activities for all five isoforms (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). The search results demonstrated clear maximum likelihoods for each thermodynamic parameter (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1e</xref>), indicative of the qualitative correctness of the activating and repressing scheme outlined in <xref ref-type="fig" rid="fig4">Figure 4a</xref>. In particular, in all cases, the signs of the coupling energies between domains are preserved, that is, both <inline-formula><mml:math id="inf13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>−</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf14"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> are positive while <inline-formula><mml:math id="inf15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msub><mml:mi>g</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mo>−</mml:mo><mml:mi>F</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> is negative (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1e</xref>), demonstrating the robustness and validity of the opposing frustration-based control mechanism underlying allostery in GR.</p></sec><sec id="s2-4"><title>Model prediction and validation</title><p>To further test the model, we sought to identify and ablate the repression component of the mechanism and quantitatively evaluated the impact on the natural GR isoforms. To do this, we targeted the interaction between the R-domain of the A isoform (i.e. R<sub>A</sub>, residues 1–97) and the DBD (<xref ref-type="fig" rid="fig1">Figure 1</xref> inset), by determining the impact of point mutations in the DBD on DNA binding affinity in the presence and absence of the tethered R-domain. For constructs containing only the DBD and the R-domain, DBD mutations could perturb either the stability of the DBD, the coupling between the DBD and the R-domain, or both. Thus, by expressing the mutant forms as linker-DBD and R<sub>A</sub>-linker-DBD constructs, using an inert linker to substitute for the F-domain (<xref ref-type="fig" rid="fig6">Figure 6a</xref>), the impact of the mutations could be clearly discerned. Mutations that affect stability of the DBD are predicted to affect the DNA-binding affinity of both constructs (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, left). However, mutations that affect the coupling between the R-domain and the DBD are predicted to impact the DNA-binding affinity of only the R<sub>A</sub>-linker-DBD construct, leaving the activity of the linker-DBD construct unaffected (<xref ref-type="fig" rid="fig6">Figure 6b</xref>, right). Screening of conserved surface residues on the DBD (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a</xref>), which did not significantly affect DBD stability or the coupling between the F-domain and DBD (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1b</xref>), revealed only three positions (i.e. C431, V435, and L436) that exhibited the expected signature of DBD residues that mediate coupling to the R-domain (<xref ref-type="fig" rid="fig6">Figure 6c</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1c and d</xref>). Consistent with these positions exerting their effects through a common mechanism, all three residues mapped to a conserved contiguous surface on the DBD (<xref ref-type="fig" rid="fig6">Figure 6d</xref>).</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.30688.011</object-id><label>Figure 6.</label><caption><title>Contiguous surface mediates coupling between the DBD and the R-domain.</title><p>(<bold>a</bold>) Schematic representation of the constructs used to identify residues on DBD involved in coupling to the R-domain. (<bold>b</bold>) EAM predicted changes in binding affinity for mutations that affect the stability of the DBD (left) or the coupling of the R-domain and the DBD (right) in the different constructs shown in a. (<bold>c</bold>) Experimental competitive transfection assays for single point mutants of both constructs shown in a. Error bars reflect uncertainty of the individual fits. (<bold>d</bold>) Cartoon of the proposed DBD surface (orange) involved in the coupling interaction with the R-domain. Shown also are the known DNA recognition helix (green helix) and the known dimerization interface (green loop). (<bold>e</bold>) Independent validation of the proposed coupling surface using the wild type and triple mutant of the A isoform, where the R-domain and the DBD are expressed in cis. The EAM predicted changes in transcriptional activity and DNA-binding affinity for mutations influencing the R-domain and the DBD coupling (from 25% to 100%) on A isoform (Model, left set of bars). Influence of the triple mutations (C431Y&amp;V435A&amp;L436A) on the transcriptional activity and the binding affinity obtained from the luciferase dosage curve of the A isoform (Experiment, right bars, detailed in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1e and f</xref>). Error bars reflect uncertainty of the individual fits. (<bold>f</bold>) Independent validation of the proposed coupling surface with the wild type and the triple mutant of the C3 isoform, with the R-domain expressed in trans. Dual luciferase assay showing the wild type and the triple mutant (i.e. C431Y/V435A/L436A) versions of the GR C3 isoform titrated with R-domain, expressed with a nuclear localization sequence and Flag tag. Error bars are 95% confidence intervals and the asterisks indicate differences that are significantly different (p&lt;0.01) by a T-test with the Benjamini-Hochberg correction for multiple tests. The y-axis is normalized to the initial, 0 ng point for each dataset. The EAM predictions in Panels b and e utilize parameters described in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1c and d</xref>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig6-v2"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30688.012</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Mutagenesis used to identify the residues in the DBD that mediate the coupling to the R-domain.</title><p>(<bold>a</bold>) Sequence conservation analysis of the DBD among the GRs in different species and among all members in the steroid hormone receptor family. Above is the secondary structure annotation of the GR DBD. Red lines label mutations on DBD investigated in this study. (<bold>b</bold>) Influence on the transcriptional activity of single point mutations carried out within DBD, on the C3 isoform. Mutations (L422A, S425G, C431Y, V435A, L436A, L482Y and Q483E) did not influence DNA-binding affinity or the coupling between DBD and F-domain, as these mutations did not significantly decrease the transcriptional activity. (<bold>c</bold>) Competitive transfection assay testing mutations (L422A, S425G, C431Y, V435A, L436A, V449A, L482Y and T493L) identified in Panel b using the linker-DBD and R<sub>A</sub>-linker-DBD constructs. Curves are shown for the mutations with different effect on the two constructs. (<bold>d</bold>) <italic>EC</italic><sub>50</sub> was fitted from each competitive transfection curve (shown in c) and expressed as relative binding affinity to wild-type construct. (<bold>e</bold>) Luciferase assay dosage curves for the triple mutants A C431Y&amp;V435A&amp;L436A and C3 C431Y&amp;V435A&amp;L436A compared to their respective wild types A and C3. Curves are fitted to the data using the dose-response function, <inline-formula><mml:math id="inf16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>F</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mo form="prefix" movablelimits="true">max</mml:mo></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>E</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo fence="true" maxsize="1.2em" minsize="1.2em" stretchy="true" symmetric="true">/</mml:mo></mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>P</mml:mi></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></inline-formula>. Data fitting details are described in the Supplementary <xref ref-type="fig" rid="fig1">Figure 1a</xref> legend. (<bold>f</bold>) Maximum transcriptional activity and binding affinity of the triple mutants of A and C3 isoforms expressed as relative to their wild types. The effect on transcriptional activity and binding affinity of A and C3 isoforms by mutating residues on DBD can be predicted by the EAM for three scenarios: decreasing the DBD stability (<bold>g</bold>), decreasing the coupling between the F-domain and the DBD (<bold>h</bold>), and decreasing the coupling between the R-domain and the DBD (i). Comparing the experimental result (shown in panel f) with the EAM predictions confirms that the triple mutations C431Y/V435A/L436A significantly decrease the coupling between the R-domain and the DBD.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-30688-fig6-figsupp1-v2"/></fig></fig-group><p>To qualitatively and quantitatively test the frustration-based control mechanism, the triple mutation (C431Y/V435A/L436A) was introduced into the full-length GR A isoform. Because the mutation should decrease the stabilizing effect of binding DNA on the R-domain, which in turn, should lower the destabilizing effect on the F-domain, the model predicts the counter-intuitive result whereby the activity of the triple mutant should increase, while the DBD-DNA binding affinity should decrease (<xref ref-type="fig" rid="fig6">Figure 6e</xref> Model). Importantly, such a prediction is the direct result of the frustration in the system and would represent a compelling argument for the competing energetic couplings shown in <xref ref-type="fig" rid="fig4">Figure 4a</xref>.</p><p>True to the prediction (<xref ref-type="fig" rid="fig6">Figure 6e</xref> Experiment), the effect of the triple mutant is a decrease in affinity for DNA while concomitantly increasing the transcriptional activity. This result is particularly important because while the modulatory role of the residues we refer to as the R-domain has been known (<xref ref-type="bibr" rid="bib3">Bender et al., 2013</xref>), previous interpretations attributed the effect to simple steric occlusion (<xref ref-type="bibr" rid="bib3">Bender et al., 2013</xref>). Our results unequivocally demonstrate that the R-domain not only negatively affects the F-domain (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref>) but also positively affects the wild-type DBD (<xref ref-type="fig" rid="fig3">Figure 3</xref>), increasing the affinity of the DBD for DNA (<xref ref-type="fig" rid="fig3">Figure 3</xref>), and it does so in a manner that is directly related to the stabilities and coupling energies in the system.</p><p>Furthermore, the facts that the three residues implicated in the coupling were independently identified through mutational analysis (<xref ref-type="fig" rid="fig6">Figure 6c</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1b–d</xref>), but nonetheless mapped to a conserved contiguous surface on the DBD (<xref ref-type="fig" rid="fig6">Figure 6d</xref>), strongly supports a model whereby these residues affect the coupling between the DBD and the R-domain through a common mechanism involving direct interactions between domains. Further supporting this notion, titration of the DBD of the C3 isoform and the C3 triple mutant (C431Y&amp;V435A&amp;L436A) with the R-domain (expressed in trans), using the luciferase assay as a reporter, clearly shows a greater concentration dependence of activity for the wild-type C3 isoform over the triple mutant (<xref ref-type="fig" rid="fig6">Figure 6f</xref>). This result indicates that the R-domain can exert its stabilization effect on the DBD through mass action, suggestive of a direct interaction involving residues C431, V435, and L436. We note that although the combination of comparatively weak coupling energies (based on the maximum likelihood parameter estimation for <inline-formula><mml:math id="inf17"><mml:mo>∆</mml:mo><mml:msub><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>-</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>; Fig. S3e) and poor solubility of both the DBD and R-domains precluded attempts to structurally characterize the interaction using NMR, such limitations have not adversely affected our efforts to rationally intervene. Indeed, <xref ref-type="fig" rid="fig6">Figure 6</xref> reveals that the coupling between the R-domain and the DBD, identified in isolation (<xref ref-type="fig" rid="fig3">Figure 3</xref>), could not only be leveraged into a comprehensive frustration-based model that quantitatively captures the relative binding and activity of all the GR isoforms (<xref ref-type="fig" rid="fig5">Figure 5b</xref>), but could also be rationally manipulated, and the opposing consequences on DNA binding and transcriptional activity predictably altered (<xref ref-type="fig" rid="fig6">Figure 6e</xref>). Thus, although physical basis of the couplings between the domains awaits future studies, the fact that GR has evolved the ability to produce isoforms that utilize different degrees of energetic frustration opens entirely new avenues for investigating regulation in IDPs.</p><p>The regulatory role of the isoform-specific ID R-domain in GR is especially important in light of the observation that the DNA sequences coding for ID regions are enriched in splice sites (<xref ref-type="bibr" rid="bib5">Buljan et al., 2012</xref>), leading to a high degree of variability in the ID regions of the resultant proteins. The studies presented here provide a functional explanation. Alternative splicing, like the alternative translation start sites of GR described here, can produce proteins with different degrees of frustration in their ID regions, and thus differing activities. In addition, isoforms may also have different combinations of post-translational modification sites, which are also enriched in ID segments (<xref ref-type="bibr" rid="bib2">Bah and Forman-Kay, 2016</xref>). By combining regulatory elements possessing different stabilities with different numbers and types of modification sites, ID proteins can potentially regulate not only the efficiency of the resultant protein, as shown here for GR, but also how that activity can be tuned by different types of modifications (<xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>).</p></sec><sec id="s2-5"><title>Conclusions</title><p>We have shown that GR produces different isoforms, which have different DNA-binding affinities and transcriptional activities that are uncorrelated to each other. Our results show that this uncorrelated behavior is facilitated through ‘energetic frustration’, wherein opposing energetic couplings compete to modulate the overall response. Recent studies reveal that in addition to being facilitated by structured proteins, allostery can also be mediated by dynamic and even ID proteins (<xref ref-type="bibr" rid="bib12">Freiburger et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Petit et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Popovych et al., 2006</xref>; <xref ref-type="bibr" rid="bib45">Tzeng and Kalodimos, 2009</xref>, <xref ref-type="bibr" rid="bib46">2012</xref>). Within these ubiquitous ID systems, significant heterogeneity, both in the apo and ligand-bound states, produces ensembles that cannot be treated using classic deterministic or structure-based allosteric models. Instead, extension of these classic models to account for positive and negative couplings between different regions provides a framework for understanding not only how ID sequences communicate with other structured and ID sequences, but also how such heterogeneity can produce complex regulatory strategies, such as the frustration-based mechanism identified here.</p></sec></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><sec id="s3-1"><title>Plasmids</title><p>DNA 2.0 (Menlo Park, CA) synthesized the plasmid used to express the A isoform of human GR in U-2 OS cells. The construct sequence was codon optimized and inserted into the PJ603 mammalian expression vector under CMV promoter control. Plasmids to express isoforms B, C1, C2, C3, D1, D2, D3 and DBD were made by inserting the codons for each respective isoform amplified from A isoform vector into the NheI and XhoI sites of the PJ603 vector. The GR F-Gal4 DBD plasmid was also produced by DNA 2.0 using the PJ603 plasmid backbone. The R<sub>A</sub>-linker-DBD (equivalent to R<sub>A</sub>-11aa linker-DBD)/R<sub>A</sub>-20aa linker-DBD plasmid was made using a PCR that deleted the codons for GR 98–420 from the GR A isoform plasmid, then digesting with BamHI and KpnI, and ligating the sticky ends to an oligo coding for the 11aa linker GTGGSGGSGGS/20 aa linker GTGGSGGSGGSGGSGGSGGS. Plasmids for R<sub>A</sub>Δ86–97-linker-DBD, R<sub>A</sub>Δ27–97-linker-DBD, R<sub>B</sub> -linker-DBD, R<sub>C1</sub> -linker -DBD, R<sub>C2</sub> -linker and linker-DBD were made by inserting the codons for each construct amplified from R<sub>A</sub>-11aa linker-DBD plasmid into the NheI and XhoI site of PJ603 vector. For the R domain-nuclear localization sequence-Flag construct, a GeneBlock was synthesized by IDT (Coralville, IA) to contain the GR R-region (1–97 a.a.), a four amino acid GSGS linker, the GR nuclear localization sequence (488–505 a.a.), a GSGSGS linker, and the FLAG tag (DYKDDDDK). This GeneBlock was restriction digested with NheI and XhoI, then inserted into the pJ603 vector (DNA2.0). The FLAG tag was used for immunostaining to verify nuclear localization (data not shown). All the point mutations on GR constructs were made by site directed mutagenesis (<xref ref-type="bibr" rid="bib18">Hemsley et al., 1989</xref>).</p><p>To measure transcriptional activity in the dual luciferase reporter assay, two tandem full length GREs (5’-aattcAGAACAggaTGTTCTgagatccgtagcAGAACAggaTGTTCTgagatccgtagcg −3’) were cloned into the EcoRI and BamHI sites in the promoter region of pGluc-miniTK vector (NEB, Ipswitch, MA), which expresses a secreted <italic>Gaussia</italic> luciferase (<xref ref-type="bibr" rid="bib44">Tannous et al., 2005</xref>). For the competitive transfection assay, four tandem half-site GREs (5’-aattcAGAACAggagagatcgtagc AGAACAggaagatccgtagcAGAACAggagagatccgtagcAGAACAggaagatccgtagcg-3’) were cloned into the promoter region of pGluc-miniTK vector. The pCluc-miniTK2 vector (NEB), expressing a secreted <italic>Cypridina</italic> luciferase (<xref ref-type="bibr" rid="bib37">Nakajima et al., 2004</xref>) independent of GR regulation, was utilized as an internal control in the transfection to account for differences in cell density and transfection efficiency in each well.</p><p>DNA 2.0 also synthesized the plasmid for bacterial expression of the two-domain GR construct. Codons for the two-domain construct of A isoform was optimized for bacterial cell expression and inserted into the PJ411 expression vector under T7 promoter control. Plasmids to express isoforms B, C1, C2, C3, D1, D2 and D3 in <italic>E.coli</italic> were made by inserting the codons for each respective isoform amplified from A isoform plasmid into the NdeI and XhoI sites of the PJ411 vector.</p></sec><sec id="s3-2"><title>Protein expression and purification</title><p>Expression, purification and storage of the two-domain constructs for the eight GR translational isoforms were the same as for the single N-terminal domain construct, as described previously (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>), except for the following modifications in the purification steps. The lysis buffer was composed of 100 mM NaH<sub>2</sub>PO<sub>4</sub>, 10 mM Tris, 500 mM NaCl, 20 mM imidazole, pH 8.0. The wash buffer was the lysis buffer containing 60 mM imidazole, and the elution buffer was the lysis buffer containing 200 mM imidazole.</p></sec><sec id="s3-3"><title>DNA-binding affinity monitored by fluorescence anisotropy change</title><p>Fluorescent Oligos containing half site GRE (5’−6-FAM gcgcAGAACAggacgcg-3’ and 5’-cgcgtccTGTTCTgcgc-3’) were synthesized by IDT with HPLC grade purification and annealed with each other to get double stranded 6FAM-labeled half site GRE. The binding experiments of GR two domain constructs with the half site GRE were carried out in the following buffer: 10 mM HEPES (pH7.6), 80 mM NaCl, 1 mM EDTA, 5 mM MgCl<sub>2</sub>, 1 mM DTT, 200 ug/mL BSA and 5 μM double strand control oligo (5’-GCGCCATATGATACGCG-3’). For each data point, 25 nM 6-FAM-labeled half site GRE was incubated with from 0 μM to 10 μM GR two-domain construct at 22°C for 30 min. Fluorescence anisotropy was measured using an Aviv ATF 105 fluorometer equipped with polarizers. A ‘sub micro’ fluorometer cell with 150 μL of solution was allowed to rest at 22°C (Santa Cells) for 2 min to allow for temperature stabilization and then excited at 495 nm. Anisotropy at 521 nm was recorded as a function of GR construct concentration and fitted with a single-site-binding model.</p></sec><sec id="s3-4"><title>Osmolyte TMAO induced protein folding transitions</title><p>TMAO-induced protein folding transitions were described previously (<xref ref-type="bibr" rid="bib28">Li et al., 2012</xref>).</p></sec><sec id="s3-5"><title>Cell culture</title><p>U-2 OS cells (American Type Culture Collection, Manassas, VA) were maintained in modified McCoy's 5a medium (Corning Cellgro, Tewksbury, MA) supplemented with 10% fetal bovine serum and 100 U/mL penicillin and 100 µg/mL streptomycin. To transfect U-2 OS cells at about 80–90% confluence, X-tremeGENE HP DNA transfection reagent (Roche, Indianapolis, IN) was used at 2 μl per 1 μg DNA according to the manufacturer’s manual.</p></sec><sec id="s3-6"><title>Transcriptional activity by dual luciferase reporter assay</title><p>For the transcriptional activity dosage curve, 40 ng of pGluc-miniTK vector with two tandem full length GREs cloned in the promoter region, 40 ng of pCluc-miniTK2 and up to 5 ng (saturating) of GR expression vector were co-transfected into U-2 OS cells on 96-well plates. For the competitive transfection assay, 40 ng of pGluc-miniTK vector with four tandem half site GREs cloned in the promoter region, 40 ng of pCluc-miniTK2, 3 ng of expression vector for C3 isoform, and up to 16 ng of plasmid coding for one of the competitors were co-transfected into U-2 OS cells on 96-well plates. For titration of the C3 isoform wild type and C3 C431Y&amp;V435A&amp;L436A mutant with the R domain-nuclear localization sequence-Flag construct, the method was the same as the competitive transfection assay described above, except up to 12 ng of the R domain-nuclear localization sequence-Flag construct plasmid was used in the titration. After 48 hr, <italic>Gaussia</italic> Luciferase activity and <italic>Cypridina</italic> Luciferase activity were measured with the BioLux <italic>Gaussia</italic> Luciferase Assay Kit (NEB) and the BioLux <italic>Cypridina</italic> Luciferase Assay Kit (NEB), respectively, on a TriStar LB 942 Multidetection Microplate Reader (Berthold Technologies GmbH &amp; Co. KG, Bad Wildbad, Germany), according to the manufacturer’s protocols. In each experiment, the <italic>Gaussia</italic> luciferase activity (normalized by the <italic>Cypridina</italic> luciferase activity) was measured in triplicate and averaged. The dosage and competitive transfection curves were fitted with dose response curves using Origin.</p></sec><sec id="s3-7"><title>Western blot</title><p>U-2 OS cells were plated on 6-well plates at a density of 5 × 10<sup>5</sup> cells per well. After 18 hr, 50 ng of GR expression vector and 450 ng of salmon sperm DNA (Invitrogen, Carlsbad, CA, transfection boosting reagent) were transfected into each well with X-tremeGENE HP DNA transfection reagent (Roche), following the manufacturer’s protocol. The medium was changed once 24 hr post transfection. After 48 hr, the cells were scraped from each well with PBS, and pelleted by centrifuging at 1500 rpm. For lysis, 50 μL of lysis buffer (8 M urea, 20 mM Tris-HCl, 500 mM NaCl, 1 mM Na<sub>2</sub>EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na<sub>3</sub>VO<sub>4</sub> and 1 µg/ml leupeptin, pH 7.5) was added to each cell pellet. To reduce the viscosity, cells were passed through a 26G 3/8’’ syringe needle 10 times and then the cell lysate was centrifuged at 14000 rpm for 30 min. Supernatant was collected and the total protein concentration was measured by Bradford assay (Bio-Rad, Hercules, CA). In each well of a 4–15% Mini-PROTEAN TGX Precast Gel (Bio-Rad), 5 µg of total protein was loaded, and separated in Tris/Glycine/SDS gel running buffer. Transfer of the protein from the SDS page gel to PVDF film was done in the transfer buffer (25 mM Tris-HCl, pH 8.3, 192 mM glycine, 20% methanol) under 120V for 15 min. After blocking in 5% nonfat milk in PBS with 0.1% Tween-20 (PBST) for 1 hr, the PVDF film was then incubated at 4˚C overnight with 10000 fold diluted primary antibody for GR (BD Transduction Laboratories, #611226, San Jose, CA) or p150glued (BD Transduction Laboratories, #610473), which served as loading control. Both antibodies were diluted into the same 5% nonfat milk in PBST. The next morning, after washing with PBST buffer for three times, the PVDF film was incubated in the 20000 fold diluted HRP-linked anti-mouse IgG (GE healthcare, NA931, Chicago, IL), also in the 5% nonfat milk in PBST. The detection was done with Amersham ECL Prime Western blotting reagent (GE heathcare, RPN2232) and autoradiography film (Denville Scientific).</p></sec><sec id="s3-8"><title>Immunostaining</title><p>U-2 OS cells were plated on 6-well plates with 15 mm round German coverslips. All the culture and transfection procedures are the same as done for the cells for western blot experiments. After 48 hr, cells were rinsed with PBSM (PBS with 2 mM MgCl<sub>2</sub>) three times, and fixed with 4% paraformaldehyde in PBSM at room temperature for 10 min. Afterwards, each coverslip was rinsed with PBSM three times again, and quenched with 50 mM NH<sub>4</sub>Cl in PBSM. Then the slide was placed in PBSTB (PBS with 0.1% Triton X-100, 1% BSA) for 30 min at room temperature to permeabilize cells and block nonspecific binding. Thereafter, the slide was incubated for 1 hr at room temperature with primary rabbit antibody for GR (cell signaling, #3660), which was 5000 fold diluted in PBSTB. Then the slide was washed three times with PBSM and incubated for 30 min at room temperature in the dark with the Alexa Fluor 488 Goat Anti-Rabbit IgG (Invitrogen, Carlsbad, CA), which was 600 fold diluted in PBSTB. Next the slide was incubated for 10 min at room temperature in the dark in PBSM with 0.2 μg/mL DAPI (Invitrogen) and 5 unit/mL Rhodamine Phalloidin (Invitrogen) to stain the nuclei and F-actin respectively. After that, each slide was washed with PBSM twice and mounted onto a microscope slide with Fluoromount (Sigma, St. Louis, MO), and kept in the dark for drying.</p><p>Images were taken with an inverted light microscope (Axiovert 200, JHU Integrated Imaging Center). All images were taken the same day using the same gain, exposure times, and filter configurations (DAPI, FITC, and Texas Red filters). The images were analyzed using ImageJ (<xref ref-type="bibr" rid="bib43">Staal et al., 2004</xref>).</p></sec><sec id="s3-9"><title>Ensemble allosteric model</title><p>The Ensemble Allosteric Model (EAM) and its usage have been described in detail previously (<xref ref-type="bibr" rid="bib20">Hilser and Thompson, 2007</xref>; <xref ref-type="bibr" rid="bib22">Hilser et al., 2012</xref>; <xref ref-type="bibr" rid="bib36">Motlagh et al., 2014</xref>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by National Science Foundation grant MCB1330211 and National Institutes of Health grants GM-063747 and T32-GM008403.</p></ack><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Software, Formal analysis, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Software, Formal analysis, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Formal analysis, Supervision, Validation, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Formal analysis, Supervision, Investigation, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Validation, Visualization, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.30688.013</object-id><label>Supplementary file 1.</label><caption><title>Mathematica notebook for data fitting.</title></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-30688-supp1-v2.nb"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.30688.014</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-30688-transrepform-v2.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auton</surname> <given-names>M</given-names></name><name><surname>Bolen</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Predicting the energetics of osmolyte-induced protein folding/unfolding</article-title><source>PNAS</source><volume>102</volume><fpage>15065</fpage><lpage>15068</lpage><pub-id pub-id-type="doi">10.1073/pnas.0507053102</pub-id><pub-id pub-id-type="pmid">16214887</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bah</surname> <given-names>A</given-names></name><name><surname>Forman-Kay</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Modulation of intrinsically disordered protein function by post-translational modifications</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>6696</fpage><lpage>6705</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.695056</pub-id><pub-id pub-id-type="pmid">26851279</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname> <given-names>IK</given-names></name><name><surname>Cao</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>NZ</given-names></name><name><surname>Nz</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Determinants of the heightened activity of glucocorticoid receptor translational isoforms</article-title><source>Molecular Endocrinology</source><volume>27</volume><fpage>1577</fpage><lpage>1587</lpage><pub-id pub-id-type="doi">10.1210/me.2013-1009</pub-id><pub-id pub-id-type="pmid">23820903</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryngelson</surname> <given-names>JD</given-names></name><name><surname>Wolynes</surname> <given-names>PG</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Spin glasses and the statistical mechanics of protein folding</article-title><source>PNAS</source><volume>84</volume><fpage>7524</fpage><lpage>7528</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.21.7524</pub-id><pub-id pub-id-type="pmid">3478708</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buljan</surname> <given-names>M</given-names></name><name><surname>Chalancon</surname> <given-names>G</given-names></name><name><surname>Eustermann</surname> <given-names>S</given-names></name><name><surname>Wagner</surname> <given-names>GP</given-names></name><name><surname>Fuxreiter</surname> <given-names>M</given-names></name><name><surname>Bateman</surname> <given-names>A</given-names></name><name><surname>Babu</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks</article-title><source>Molecular Cell</source><volume>46</volume><fpage>871</fpage><lpage>883</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.039</pub-id><pub-id pub-id-type="pmid">22749400</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>Y</given-names></name><name><surname>Bender</surname> <given-names>IK</given-names></name><name><surname>Konstantinidis</surname> <given-names>AK</given-names></name><name><surname>Shin</surname> <given-names>SC</given-names></name><name><surname>Jewell</surname> <given-names>CM</given-names></name><name><surname>Cidlowski</surname> <given-names>JA</given-names></name><name><surname>Schleimer</surname> <given-names>RP</given-names></name><name><surname>Lu</surname> <given-names>NZ</given-names></name><name><surname>Nz</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans</article-title><source>Blood</source><volume>121</volume><fpage>1553</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-05-432336</pub-id><pub-id pub-id-type="pmid">23297131</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Srinivasan</surname> <given-names>G</given-names></name><name><surname>Thompson</surname> <given-names>EB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Protein-protein interactions are implied in glucocorticoid receptor mutant 465*-mediated cell death</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><fpage>25873</fpage><lpage>25880</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.41.25873</pub-id><pub-id pub-id-type="pmid">9325319</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlman-Wright</surname> <given-names>K</given-names></name><name><surname>Almlöf</surname> <given-names>T</given-names></name><name><surname>McEwan</surname> <given-names>IJ</given-names></name><name><surname>Gustafsson</surname> <given-names>JA</given-names></name><name><surname>Wright</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression</article-title><source>PNAS</source><volume>91</volume><fpage>1619</fpage><lpage>1623</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.5.1619</pub-id><pub-id pub-id-type="pmid">8127854</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyson</surname> <given-names>HJ</given-names></name><name><surname>Wright</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Coupling of folding and binding for unstructured proteins</article-title><source>Current Opinion in Structural Biology</source><volume>12</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(02)00289-0</pub-id><pub-id pub-id-type="pmid">11839490</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreon</surname> <given-names>AC</given-names></name><name><surname>Ferreon</surname> <given-names>JC</given-names></name><name><surname>Wright</surname> <given-names>PE</given-names></name><name><surname>Deniz</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modulation of allostery by protein intrinsic disorder</article-title><source>Nature</source><volume>498</volume><fpage>390</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1038/nature12294</pub-id><pub-id pub-id-type="pmid">23783631</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname> <given-names>J</given-names></name><name><surname>McEwan</surname> <given-names>IJ</given-names></name><name><surname>Wright</surname> <given-names>AP</given-names></name><name><surname>Gustafsson</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Involvement of the transcription factor IID protein complex in gene activation by the N-terminal transactivation domain of the glucocorticoid receptor in vitro</article-title><source>Molecular Endocrinology</source><volume>11</volume><fpage>1467</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1210/mend.11.10.9995</pub-id><pub-id pub-id-type="pmid">9280062</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freiburger</surname> <given-names>LA</given-names></name><name><surname>Baettig</surname> <given-names>OM</given-names></name><name><surname>Sprules</surname> <given-names>T</given-names></name><name><surname>Berghuis</surname> <given-names>AM</given-names></name><name><surname>Auclair</surname> <given-names>K</given-names></name><name><surname>Mittermaier</surname> <given-names>AK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Competing allosteric mechanisms modulate substrate binding in a dimeric enzyme</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>18</volume><fpage>288</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1978</pub-id><pub-id pub-id-type="pmid">21278754</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Pino</surname> <given-names>A</given-names></name><name><surname>Balasubramanian</surname> <given-names>S</given-names></name><name><surname>Wyns</surname> <given-names>L</given-names></name><name><surname>Gazit</surname> <given-names>E</given-names></name><name><surname>De Greve</surname> <given-names>H</given-names></name><name><surname>Magnuson</surname> <given-names>RD</given-names></name><name><surname>Charlier</surname> <given-names>D</given-names></name><name><surname>van Nuland</surname> <given-names>NA</given-names></name><name><surname>Loris</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity</article-title><source>Cell</source><volume>142</volume><fpage>101</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.05.039</pub-id><pub-id pub-id-type="pmid">20603017</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godowski</surname> <given-names>PJ</given-names></name><name><surname>Rusconi</surname> <given-names>S</given-names></name><name><surname>Miesfeld</surname> <given-names>R</given-names></name><name><surname>Yamamoto</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement</article-title><source>Nature</source><volume>325</volume><fpage>365</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1038/325365a0</pub-id><pub-id pub-id-type="pmid">3808033</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griekspoor</surname> <given-names>A</given-names></name><name><surname>Zwart</surname> <given-names>W</given-names></name><name><surname>Neefjes</surname> <given-names>J</given-names></name><name><surname>Michalides</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Visualizing the action of steroid hormone receptors in living cells</article-title><source>Nuclear Receptor Signaling</source><volume>5</volume><elocation-id>e003</elocation-id><pub-id pub-id-type="doi">10.1621/nrs.05003</pub-id><pub-id pub-id-type="pmid">17464358</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gronemeyer</surname> <given-names>H</given-names></name><name><surname>Bourguet</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Allosteric effects govern nuclear receptor action: DNA appears as a player</article-title><source>Science Signaling</source><volume>2</volume><elocation-id>pe34</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.273pe34</pub-id><pub-id pub-id-type="pmid">19491383</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>TW</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Xie</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>LC</given-names></name><name><surname>Mirzaei</surname> <given-names>H</given-names></name><name><surname>Pei</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Xiao</surname> <given-names>G</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies</article-title><source>Cell</source><volume>149</volume><fpage>768</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.04.016</pub-id><pub-id pub-id-type="pmid">22579282</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemsley</surname> <given-names>A</given-names></name><name><surname>Arnheim</surname> <given-names>N</given-names></name><name><surname>Toney</surname> <given-names>MD</given-names></name><name><surname>Cortopassi</surname> <given-names>G</given-names></name><name><surname>Galas</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>A simple method for site-directed mutagenesis using the polymerase chain reaction</article-title><source>Nucleic Acids Research</source><volume>17</volume><fpage>6545</fpage><lpage>6551</lpage><pub-id pub-id-type="doi">10.1093/nar/17.16.6545</pub-id><pub-id pub-id-type="pmid">2674899</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilser</surname> <given-names>VJ</given-names></name><name><surname>García-Moreno E</surname> <given-names>B</given-names></name><name><surname>Oas</surname> <given-names>TG</given-names></name><name><surname>Kapp</surname> <given-names>G</given-names></name><name><surname>Whitten</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A statistical thermodynamic model of the protein ensemble</article-title><source>Chemical Reviews</source><volume>106</volume><fpage>1545</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1021/cr040423+</pub-id><pub-id pub-id-type="pmid">16683744</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilser</surname> <given-names>VJ</given-names></name><name><surname>Thompson</surname> <given-names>EB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Intrinsic disorder as a mechanism to optimize allosteric coupling in proteins</article-title><source>PNAS</source><volume>104</volume><fpage>8311</fpage><lpage>8315</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700329104</pub-id><pub-id pub-id-type="pmid">17494761</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilser</surname> <given-names>VJ</given-names></name><name><surname>Thompson</surname> <given-names>EB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>39675</fpage><lpage>39682</lpage><pub-id pub-id-type="doi">10.1074/jbc.R111.278929</pub-id><pub-id pub-id-type="pmid">21937423</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilser</surname> <given-names>VJ</given-names></name><name><surname>Wrabl</surname> <given-names>JO</given-names></name><name><surname>Motlagh</surname> <given-names>HN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structural and energetic basis of allostery</article-title><source>Annual Review of Biophysics</source><volume>41</volume><fpage>585</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-050511-102319</pub-id><pub-id pub-id-type="pmid">22577828</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenberg</surname> <given-names>SM</given-names></name><name><surname>Evans</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Multiple and cooperative trans-activation domains of the human glucocorticoid receptor</article-title><source>Cell</source><volume>55</volume><fpage>899</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(88)90145-6</pub-id><pub-id pub-id-type="pmid">3191531</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koshland</surname> <given-names>DE</given-names></name><name><surname>Némethy</surname> <given-names>G</given-names></name><name><surname>Filmer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>Comparison of experimental binding data and theoretical models in proteins containing subunits</article-title><source>Biochemistry</source><volume>5</volume><fpage>365</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1021/bi00865a047</pub-id><pub-id pub-id-type="pmid">5938952</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraulis</surname> <given-names>PJ</given-names></name><name><surname>Raine</surname> <given-names>AR</given-names></name><name><surname>Gadhavi</surname> <given-names>PL</given-names></name><name><surname>Laue</surname> <given-names>ED</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Structure of the DNA-binding domain of zinc GAL4</article-title><source>Nature</source><volume>356</volume><fpage>448</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1038/356448a0</pub-id><pub-id pub-id-type="pmid">1557129</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishna</surname> <given-names>S</given-names></name><name><surname>Semsey</surname> <given-names>S</given-names></name><name><surname>Jensen</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Frustrated bistability as a means to engineer oscillations in biological systems</article-title><source>Physical Biology</source><volume>6</volume><elocation-id>036009</elocation-id><pub-id pub-id-type="doi">10.1088/1478-3975/6/3/036009</pub-id><pub-id pub-id-type="pmid">19461130</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefstin</surname> <given-names>JA</given-names></name><name><surname>Yamamoto</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Allosteric effects of DNA on transcriptional regulators</article-title><source>Nature</source><volume>392</volume><fpage>885</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/31860</pub-id><pub-id pub-id-type="pmid">9582068</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Motlagh</surname> <given-names>HN</given-names></name><name><surname>Chakuroff</surname> <given-names>C</given-names></name><name><surname>Thompson</surname> <given-names>EB</given-names></name><name><surname>Hilser</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Thermodynamic dissection of the intrinsically disordered N-terminal domain of human glucocorticoid receptor</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>26777</fpage><lpage>26787</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.355651</pub-id><pub-id pub-id-type="pmid">22669939</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Perumal</surname> <given-names>NB</given-names></name><name><surname>Oldfield</surname> <given-names>CJ</given-names></name><name><surname>Su</surname> <given-names>EW</given-names></name><name><surname>Uversky</surname> <given-names>VN</given-names></name><name><surname>Dunker</surname> <given-names>AK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Intrinsic disorder in transcription factors</article-title><source>Biochemistry</source><volume>45</volume><fpage>6873</fpage><lpage>6888</lpage><pub-id pub-id-type="doi">10.1021/bi0602718</pub-id><pub-id pub-id-type="pmid">16734424</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>NZ</given-names></name><name><surname>Cidlowski</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes</article-title><source>Molecular Cell</source><volume>18</volume><fpage>331</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.03.025</pub-id><pub-id pub-id-type="pmid">15866175</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>NZ</given-names></name><name><surname>Cidlowski</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Glucocorticoid receptor isoforms generate transcription specificity</article-title><source>Trends in Cell Biology</source><volume>16</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2006.04.005</pub-id><pub-id pub-id-type="pmid">16697199</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum</surname> <given-names>JK</given-names></name><name><surname>Neuweiler</surname> <given-names>H</given-names></name><name><surname>Fersht</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53</article-title><source>Journal of the American Chemical Society</source><volume>134</volume><fpage>1617</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1021/ja2078619</pub-id><pub-id pub-id-type="pmid">22176582</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijsing</surname> <given-names>SH</given-names></name><name><surname>Pufall</surname> <given-names>MA</given-names></name><name><surname>So</surname> <given-names>AY</given-names></name><name><surname>Bates</surname> <given-names>DL</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Yamamoto</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>DNA binding site sequence directs glucocorticoid receptor structure and activity</article-title><source>Science</source><volume>324</volume><fpage>407</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1126/science.1164265</pub-id><pub-id pub-id-type="pmid">19372434</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monod</surname> <given-names>J</given-names></name><name><surname>Wyman</surname> <given-names>J</given-names></name><name><surname>Changeux</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>On the nature of allosteric transitions: A plausible model</article-title><source>Journal of Molecular Biology</source><volume>12</volume><fpage>88</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(65)80285-6</pub-id><pub-id pub-id-type="pmid">14343300</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motlagh</surname> <given-names>HN</given-names></name><name><surname>Hilser</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Agonism/antagonism switching in allosteric ensembles</article-title><source>PNAS</source><volume>109</volume><fpage>4134</fpage><lpage>4139</lpage><pub-id pub-id-type="doi">10.1073/pnas.1120519109</pub-id><pub-id pub-id-type="pmid">22388747</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motlagh</surname> <given-names>HN</given-names></name><name><surname>Wrabl</surname> <given-names>JO</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Hilser</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The ensemble nature of allostery</article-title><source>Nature</source><volume>508</volume><fpage>331</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1038/nature13001</pub-id><pub-id pub-id-type="pmid">24740064</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname> <given-names>Y</given-names></name><name><surname>Kobayashi</surname> <given-names>K</given-names></name><name><surname>Yamagishi</surname> <given-names>K</given-names></name><name><surname>Enomoto</surname> <given-names>T</given-names></name><name><surname>Ohmiya</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>cDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca</article-title><source>Bioscience, Biotechnology, and Biochemistry</source><volume>68</volume><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1271/bbb.68.565</pub-id><pub-id pub-id-type="pmid">15056888</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandit</surname> <given-names>S</given-names></name><name><surname>Geissler</surname> <given-names>W</given-names></name><name><surname>Harris</surname> <given-names>G</given-names></name><name><surname>Sitlani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Allosteric effects of dexamethasone and RU486 on glucocorticoid receptor-DNA interactions</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>1538</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1074/jbc.M105438200</pub-id><pub-id pub-id-type="pmid">11682470</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname> <given-names>CM</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Sapienza</surname> <given-names>PJ</given-names></name><name><surname>Fuentes</surname> <given-names>EJ</given-names></name><name><surname>Lee</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hidden dynamic allostery in a PDZ domain</article-title><source>PNAS</source><volume>106</volume><fpage>18249</fpage><lpage>18254</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904492106</pub-id><pub-id pub-id-type="pmid">19828436</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaff</surname> <given-names>SJ</given-names></name><name><surname>Fletterick</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>15256</fpage><lpage>15267</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.108118</pub-id><pub-id pub-id-type="pmid">20335180</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popovych</surname> <given-names>N</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Ebright</surname> <given-names>RH</given-names></name><name><surname>Kalodimos</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dynamically driven protein allostery</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>13</volume><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nsmb1132</pub-id><pub-id pub-id-type="pmid">16906160</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sevcsik</surname> <given-names>E</given-names></name><name><surname>Trexler</surname> <given-names>AJ</given-names></name><name><surname>Dunn</surname> <given-names>JM</given-names></name><name><surname>Rhoades</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Allostery in a disordered protein: oxidative modifications to α-synuclein act distally to regulate membrane binding</article-title><source>Journal of the American Chemical Society</source><volume>133</volume><fpage>7152</fpage><lpage>7158</lpage><pub-id pub-id-type="doi">10.1021/ja2009554</pub-id><pub-id pub-id-type="pmid">21491910</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staal</surname> <given-names>J</given-names></name><name><surname>Abràmoff</surname> <given-names>MD</given-names></name><name><surname>Niemeijer</surname> <given-names>M</given-names></name><name><surname>Viergever</surname> <given-names>MA</given-names></name><name><surname>van Ginneken</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Ridge-based vessel segmentation in color images of the retina</article-title><source>IEEE Transactions on Medical Imaging</source><volume>23</volume><fpage>501</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1109/TMI.2004.825627</pub-id><pub-id pub-id-type="pmid">15084075</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tannous</surname> <given-names>BA</given-names></name><name><surname>Kim</surname> <given-names>DE</given-names></name><name><surname>Fernandez</surname> <given-names>JL</given-names></name><name><surname>Weissleder</surname> <given-names>R</given-names></name><name><surname>Breakefield</surname> <given-names>XO</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Codon-optimized gaussia luciferase cDNA for mammalian gene expression in culture and in vivo</article-title><source>Molecular Therapy</source><volume>11</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2004.10.016</pub-id><pub-id pub-id-type="pmid">15727940</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzeng</surname> <given-names>SR</given-names></name><name><surname>Kalodimos</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dynamic activation of an allosteric regulatory protein</article-title><source>Nature</source><volume>462</volume><fpage>368</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1038/nature08560</pub-id><pub-id pub-id-type="pmid">19924217</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzeng</surname> <given-names>SR</given-names></name><name><surname>Kalodimos</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Protein activity regulation by conformational entropy</article-title><source>Nature</source><volume>488</volume><fpage>236</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1038/nature11271</pub-id><pub-id pub-id-type="pmid">22801505</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vannimenus</surname> <given-names>J</given-names></name><name><surname>Toulouse</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Theory of the frustration effect. II. Ising spins on a square lattice</article-title><source>Journal of Physics C: Solid State Physics</source><volume>10</volume><fpage>L537</fpage><lpage>L542</lpage><pub-id pub-id-type="doi">10.1088/0022-3719/10/18/008</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villain</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Two-level systems in a spin-glass model. I. General formalism and two-dimensional model</article-title><source>Journal of Physics C: Solid State Physics</source><volume>10</volume><fpage>4793</fpage><lpage>4803</lpage><pub-id pub-id-type="doi">10.1088/0022-3719/10/23/013</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>RF</given-names></name><name><surname>Nisoli</surname> <given-names>C</given-names></name><name><surname>Freitas</surname> <given-names>RS</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>McConville</surname> <given-names>W</given-names></name><name><surname>Cooley</surname> <given-names>BJ</given-names></name><name><surname>Lund</surname> <given-names>MS</given-names></name><name><surname>Samarth</surname> <given-names>N</given-names></name><name><surname>Leighton</surname> <given-names>C</given-names></name><name><surname>Crespi</surname> <given-names>VH</given-names></name><name><surname>Schiffer</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Artificial 'spin ice' in a geometrically frustrated lattice of nanoscale ferromagnetic islands</article-title><source>Nature</source><volume>439</volume><fpage>303</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1038/nature04447</pub-id><pub-id pub-id-type="pmid">16421565</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.30688.015</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Kuriyan</surname><given-names>John</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Berkeley</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Genetically tunable frustration controls allostery in an intrinsically disordered transcription factor&quot; for consideration by <italic>eLife</italic>. Your article has been very favorably reviewed by three peer reviewers. Indeed, it relatively rare for us to see such consistency in praise for a paper under evaluation.</p><p>The evaluation has been overseen by John Kuriyan as the Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Rohit V Pappu (Reviewer #1); David Eliezer (Reviewer #2).</p><p>The manuscript needs revision, but as you will see, we are only asking for textual changes. None of the issues raised are considered to be particularly serious, and you should use your best judgement as to how to address them.</p><p>Overall comments:</p><p>Reviewer 1</p><p>This work by Hilser and coworkers continues their efforts to uncover the role of intrinsically disordered regions in allostery as exemplified in the GR family of hormone regulated transcription factors. This MS is well written, clear, and easy to follow despite the numerous constructs that one has to keep in mind. The major theme in this work, which is a continuation of the ensemble allostery model for TFs with IDRs, is the finding that different GR isoforms, distinguished entirely by differences in their N-terminal IDRs, engender different transcriptional activities entirely through differences in coupling free energies among different domains. This result shines through because the DBDs are identical in all of the constructs, and yet the authors observe a clear impact of changes to the N-terminal IDR on DNA binding and on transcriptional activity, although there is no correlation between the DNA binding affinities and activities. This family of TFs is an elegant system for dissecting the impact of IDR mediated allostery and the model appears to do a good job of recapitulating the measured activities.</p><p>Overall, this is a very strong paper, clearly written, espousing coherent concepts, and highlighting novel roles for IDRs, which go beyond speculation and anchor the findings in concrete data, that are driven by predictions. In many ways, this work exemplifies the best of science and the integrative efforts of clearly formulated statistical physics, biophysical experimentation, and evolutionary principles.</p><p>Reviewer 2</p><p>This paper describes a study to document the previously predicted phenomenon of allostery involving disordered protein regions using the glucocorticoid receptor (GR) as a model system. GR contains two functionally separable disordered regions, each of which is shown experimentally to interact favorably with the DNA-binding domain (DBD), but to interact unfavorably with each other, resulting in a frustrated system in which activity, mediated by the F domain, is enhanced directly by the DBD but is repressed indirectly via DBD-enhanced repression by the R domain. Using the model previously developed to model allostery in such system, featuring the individual stabilities of the domains and the coupling energies between each pair of domains, the authors are able to generate results that are in delightful agreement with the experimental measurements on differently spliced isoforms of GR in which the R region is present to different degrees. Even more impressively, a series of mutations is identified which are able to disrupt the coupling between the DBD and the R domain, which then show precisely the predicted effects on activity, both in cis and in trans.</p><p>This is a lovely, clear paper that beautifully demonstrates the validity and biological relevance of the model previously developed by the authors for allostery involving disordered protein regions. This is a conceptually important extension of the classical models of allostery, and in light of the ever growing importance of disordered protein regions, is a critical contribution to our understanding of protein function regulation.</p><p>Reviewer 3</p><p>In this study by Li et al. the authors have investigated the role of regions of the intrinsically disordered amino-terminal domain of the glucocorticoid receptor in allosteric regulation. Specially they have tested experimentally and further validated their previously published 'ensemble allosteric model'.</p><p>This is an excellent study and significantly contributes to our growing understanding of the role of intrinsically disordered structure and nuclear receptor signalling. The authors have used a range of molecular and biophysical methods to investigate receptor-dependent transcription, DNA binding affinity and protein folding.</p><p>Comments to address:</p><p>1) Could the title be made somewhat more accessible? The average <italic>eLife</italic> reader may not be &quot;tuned&quot; to the concept of &quot;frustration&quot;, and there is some concern that the title may not draw in all readers who should be interested in this work.</p><p>2) The terminology regarding frustration should be clarified and improved. First, several declarations are made about the history of frustration that are inaccurate. The triangular Ising net was introduced by Wannier in 1950. The discovery of frustration in ice was explained by Pauling in 1935. And the term &quot;energetic frustration&quot; is a concoction. In condensed matter physics, the term is &quot;geometric frustration&quot; or just &quot;frustration&quot;. There is a lot more to frustration theory than is alluded to here. It would be helpful to have a paragraph laying out the frustration models that the authors are connecting to, explain why this is a useful concept, and map back to this model with their data. Otherwise, there is concern that <italic>eLife</italic> readers may not find the analogies useful.</p><p>3) In the context of comment 2) above, it would help to clarify how the classification into frustrated vs. non-frustrated configurations was achieved in <xref ref-type="fig" rid="fig4">Figure 4</xref>. It looks like there are configurations that are erroneously labeled as non-frustrated ones and this is why the precepts of the model would be useful to clarify.</p><p>4) The paper does not clearly explain how the model is able to differentiate between isoforms that feature different length deletions of the R domain (isoforms A, B, C1, C2 and C3). As far as I can tell, the model only accounts for the presence of the R domain (isoform A) or its absence (isoform C3), yet predictions and experimental results are shown (<xref ref-type="fig" rid="fig5">Figure 5</xref>) for isoforms C1, C2 and C3 as well. Clarification of how this was accomplished would be welcome.</p><p>5) Many of the reported errors are noted to represent the uncertainty of the curve fits to the date, but details regarding how the curve fitting was performed and how the errors were then extracted would be welcome in the supplementary materials.</p><p>6) Regarding the choice of response elements in the different transcription and DNA binding experiments: The authors have used a standard reporter gene containing palindromic glucocorticoid response elements (GRE). However, in the transcription competition studies and DNA binding studies the focus appears to have been on half-sites (four or single respectively). The rationale for this is not clear and the binding affinity to a half site is almost certainly different from a 15 bp GRE. This needs to be made clear and the rationale for using half-sites explained and the broader consequences of the results to glucocorticoid receptor transcription. Did the authors wish to avoid dimerization of receptor isoforms complicating the measurements? Please clarify.</p><p>7) It would have been nice to see data for bona fide GREs from known glucocorticoid target genes, as these a likely to exhibit different binding affinities and/or structures, but of course there has to be a balance with technical consideration. However, the authors could comment on the action of the glucocorticoid receptor on negative GREs (ie Hua et al., 2016) with regards their allosteric model (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The 'non-frustrated' configurations would appear to be more reflective of known glucocorticoid receptor action?</p><p>8) <xref ref-type="fig" rid="fig6">Figure 6</xref>. Could the data for C3 and DNA binding domain mutant C3 be shown in part 'E'? The prediction would be that C3 activity would be immune to the triple mutation. This seems to be shown in part 'f' 0 sample, but it would be nice to see it clearly shown as it provides further support for the author's model.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.30688.016</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Comments to address:</p><p>1) Could the title be made somewhat more accessible? The average eLife reader may not be &quot;tuned&quot; to the concept of &quot;frustration&quot;, and there is some concern that the title may not draw in all readers who should be interested in this work.</p></disp-quote><p>We agree with the reviewer’s concern that the concept of “frustration” is not widely used in the biological sciences, but as it is the main point we belief it will actually draw readers. In short, we believe the title will turn out to be a strength, since the unusual terminology, for the average <italic>eLife</italic> reader, could spark curiosity and debate across disciplines.</p><p>In support of this choice, a recent high-profile review states that “… Frustration is a fundamental concept in molecular biology” (Ferreiro, et al., 2014). Our title may thus be viewed as raising current awareness of a concept that has latently existed in the biological literature for decades. We respectfully opt to retain the title without modification.</p><disp-quote content-type="editor-comment"><p>2) The terminology regarding frustration should be clarified and improved. First, several declarations are made about the history of frustration that are inaccurate. The triangular Ising net was introduced by Wannier in 1950. The discovery of frustration in ice was explained by Pauling in 1935. And the term &quot;energetic frustration&quot; is a concoction. In condensed matter physics, the term is &quot;geometric frustration&quot; or just &quot;frustration&quot;. There is a lot more to frustration theory than is alluded to here. It would be helpful to have a paragraph laying out the frustration models that the authors are connecting to, explain why this is a useful concept, and map back to this model with their data. Otherwise, there is concern that eLife readers may not find the analogies useful.</p></disp-quote><p>We thank the reviewer for pointing out how this manuscript could be more effectively couched in the historical literature.</p><p>We agree with the reviewer that the term “energetic frustration”, undeveloped as it was in the previous version, was a concoction. Because of the more than superficial analogy with the physics models, it deserves a distinguishing name. For consistency, the term “energetic frustration” has been adopted throughout the text.</p><p>Furthermore, we agree with the reviewer that our terminology regarding energetic frustration could have been articulated more clearly. Accordingly, we clarify our model in subsection “The Ensemble Allosteric Model (EAM) Enables Quantitative Characterization of the Energetic Frustration in GR”, and its analogy to geometric frustration, as follows. Our model of energetic frustration in GR is related, but not identical, to classical physics models for the interaction energies between pairs of spins in a magnet. The simplest model of spin interaction energy takes the form E<sub>int</sub> = -J<sub>ij</sub>S<sub>i</sub>S<sub>j</sub>, where J<sub>ij</sub> is the coupling between spins i and j, while S<sub>i</sub>, S<sub>j</sub> are the signs referring to up/down nature of the spins (Ferreiro, et al., 2014). Similarly, we model the interaction energy between one pair of domains in GR (or any multi-domain protein) with an analogous mathematical form, as E<sub>int</sub> = J<sub>ij</sub>(S<sub>i</sub>|∆G<sub>i</sub>)(S<sub>j</sub>|∆G<sub>j</sub>). In our model, J<sub>ij</sub> is also a coupling energy, which we instead name ∆g<sub>int</sub>, between the domains.</p><p>There are, however, three key differences between the models. First, S<sub>i</sub> and S<sub>j</sub>, though still signs as in the classical model, are constrained to the values of {0, +1}. Second, the value of the sign is conditional on the stabilities of the individual domains, ∆G<sub>i</sub> and ∆G<sub>j</sub>. If the domains are both folded, the interface between them is also folded. S<sub>i</sub> and S<sub>j</sub> then both take the value +1, and only in this case does the complete expression provide additional coupling energy ∆g<sub>int</sub> to the system. Third, the sign of J<sub>ij</sub> in our model may be either positive or negative, as allosteric coupling in different proteins has been observed to be either positive or negative.</p><p>These differences increase the theoretical complexity of the energetic frustration model, relative to the simple geometric frustration model. Thus, connecting our Ensemble Allostery Model (EAM) with physics frustration models is a useful analogy because the non-intuitive allosteric behavior exhibited by biological systems, such as GR, may be now partially understood and interpreted in terms of the classical physics models, which have been more thoroughly explored for almost a century.</p><disp-quote content-type="editor-comment"><p>3) In the context of comment 2) above, it would help to clarify how the classification into frustrated vs. non-frustrated configurations was achieved in <xref ref-type="fig" rid="fig4">Figure 4</xref>. It looks like there are configurations that are erroneously labeled as non-frustrated ones and this is why the precepts of the model would be useful to clarify.</p></disp-quote><p>We are grateful to the reviewer for making this point, as it highlights the shortcomings in the original version in explaining our model and differentiating energetic frustration from geometric frustration. We have clarified the description of <xref ref-type="fig" rid="fig4">Figure 4</xref> by stating that all configurations in the Figure are correctly labeled with respect to energetic frustration. The reason for this is that the triplets of arrows in the Figure represent a different type of interaction than the spin pairs of geometric frustration, and thus individual arrows do not represent molecular positions and neighboring pairs of arrows should not be interpreted as directly interacting with each other. Rather, each triplet arrow in the context of energetic frustration represents a domain-domain interface, and the up/down direction of the arrow represents positive or negative allosteric coupling. In the particular case of GR, these arrows are interpreted from left to right as representing the coupling between DBD- and F-domains, the coupling between R- and F-domains, and the coupling between DBD- and R-domains, respectively. DNA binding to the DBD stabilizes the DBD, and thus inputs a positive coupling energy into the system. The response of the system, i.e. transcriptional regulation, is a complex function of the competition between the direct coupling between DBD-F and the indirect coupling mediated through the R-domain.</p><p>Put another way, the energetic frustration of the system results from the numbers of up and down arrows in the triplet without regard to the exact ordering: for example, two up arrows grouped with one down will always result in a system with energetic frustration, given an input of positive coupling. Although we thought adequate explanation was given in the legend, we see now that a clearer description was necessary. We sincerely apologize for all these shortcomings. To address the reviewer’s concerns and to improve the clarity of <xref ref-type="fig" rid="fig4">Figure 4, a</xref> triplet has been added to 4A to better connect 4A to 4B, and the text and figure legend have been expanded.</p><disp-quote content-type="editor-comment"><p>4) The paper does not clearly explain how the model is able to differentiate between isoforms that feature different length deletions of the R domain (isoforms A, B, C1, C2 and C3). As far as I can tell, the model only accounts for the presence of the R domain (isoform A) or its absence (isoform C3), yet predictions and experimental results are shown (<xref ref-type="fig" rid="fig5">Figure 5</xref>) for isoforms C1, C2 and C3 as well. Clarification of how this was accomplished would be welcome.</p></disp-quote><p>All the detailed constraints for A, B, C1, C2, and C3 isoforms are in the Mathematica notebook. Indeed, the reviewer is correct that emphasis has been placed in the text on A and C3, even though the Ensemble Allosteric Model (EAM) implemented for GR can treat the other isoforms.</p><p>The key assumption influencing the predictions for the B, C1, C2 and C3 isoforms, relative to A, is a length-dependent coupling energy between DBD- and R-domains: since the A isoform of the R-domain is 97 residues and the B isoform is 71 residues we assume the coupling energy between B and DBD is roughly 80% of that observed between A and DBD. This modification is coded to variable “SWdbdRB” (abbreviation for “Statistical Weight of folded DBD and folded R domain, B-isoform”) in the fifth line of the “Partition Function for the B Isoform&quot; in the Supplemental Mathematica Notebook. Similarly, every C isoform has zero R-domain and DBD coupling energy, since the entire R-domain is missing in these isoforms; these modifications are coded explicitly as zero in line 5 of each of the C isoform partition functions.</p><p>Since the coupling energy between F-domain and DBD is also identical among the C1, C2, C3 domains, their different predicted values must arise from the fact that the EAM naturally permits different values for the intrinsic stabilities of C1 and C2 in the solution (the measured value for C3 is one of the experimental constraints).</p><disp-quote content-type="editor-comment"><p>5) Many of the reported errors are noted to represent the uncertainty of the curve fits to the date, but details regarding how the curve fitting was performed and how the errors were then extracted would be welcome in the supplementary materials.</p></disp-quote><p>Curve fitting was performed using Mathematica’s NonLinearModelFit function with all-default parameters, which automatically provides error estimates at 95% confidence intervals. These automatic error estimates are reported in the Figures without further modification. The NonLinearModelFit function assumes that errors are independent and normally distributed, and the reported fit minimizes the sum of the squared errors. Complete details can be found in the Mathematica documentation, located at: <ext-link ext-link-type="uri" xlink:href="http://reference.wolfram.com/language/tutorial/StatisticalModelAnalysis.html">http://reference.wolfram.com/language/tutorial/StatisticalModelAnalysis.html</ext-link></p><p>To address the reviewer’s concern, to the Figure supplements legends, where NonLinearModelFit was employed, we have added the phrase “…as returned by the default settings of Mathematica’s NonLinearModelFit function.”</p><disp-quote content-type="editor-comment"><p>6) Regarding the choice of response elements in the different transcription and DNA binding experiments: The authors have used a standard reporter gene containing palindromic glucocorticoid response elements (GRE). However, in the transcription competition studies and DNA binding studies the focus appears to have been on half-sites (four or single respectively). The rationale for this is not clear and the binding affinity to a half site is almost certainly different from a 15 bp GRE. This needs to be made clear and the rationale for using half-sites explained and the broader consequences of the results to glucocorticoid receptor transcription. Did the authors wish to avoid dimerization of receptor isoforms complicating the measurements? Please clarify.</p></disp-quote><p>We agree with the reviewer’s statement that the binding affinity to a half-site is almost certainly different than to a 15 bp GRE. Indeed, the reviewer is correct that we wished to avoid the complication of dimerization by using the half-site, since dimerization is reported to be palindromic-GRE dependent. In contrast, the four tandem half-site GRE was chosen in the cell assay because of its increased signal-to-noise ratio.</p><disp-quote content-type="editor-comment"><p>7) It would have been nice to see data for bona fide GREs from known glucocorticoid target genes, as these a likely to exhibit different binding affinities and/or structures, but of course there has to be a balance with technical consideration. However, the authors could comment on the action of the glucocorticoid receptor on negative GREs (ie Hua et al. 2016) with regards their allosteric model (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The 'non-frustrated' configurations would appear to be more reflective of known glucocorticoid receptor action?</p></disp-quote><p>We thank the reviewer for bringing this paper to our attention, as we are unfamiliar with this particular work. As detailed in this paper, binding of an inverted repeated negative GRE (IR nGRE) seems to require conformational change and covalent modification within the NTD (i.e. “unmasking” as described by Hua, et al.), mediated by LBD binding of a glucocorticoid. Although the LBD and covalent modifications are not modeled in our work, we can accept the point that the DBD could be structurally malleable. Thus, we could speculate that IR nGRE binding may induce a conformation of DBD that is different from the positive GRE binding in our model. How this conformation could be coupled to the R and F domains are intriguing topics for future study. We think the applicable coupling scenarios would be cases ii, iii, vi, or vii in <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</p><disp-quote content-type="editor-comment"><p>8) <xref ref-type="fig" rid="fig6">Figure 6</xref>. Could the data for C3 and DNA binding domain mutant C3 be shown in part 'E'? The prediction would be that C3 activity would be immune to the triple mutation. This seems to be shown in part 'f' 0 sample, but it would be nice to see it clearly shown as it provides further support for the author's model.</p></disp-quote><p>We are grateful to the reviewer for such a close reading of our technical data! The C3 activity is indeed immune to the triple mutation, and the reviewer is correct that it is shown in the 0 sample in panel 6F. Both activity and binding data for C3-DBD and its triple mutant are already shown together in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, panels E and F. Although we think it reasonable to do as suggested, we respectfully elect not to increase the size and complexity of panel 6E.</p></body></sub-article></article>